Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Iovance Biotherapeutics (IOVA) over the last 9 years, with Sep 2025 value amounting to -$18.1 million.

  • Iovance Biotherapeutics' Other Working Capital Changes fell 560.52% to -$18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.7 million, marking a year-over-year decrease of 4.56%. This contributed to the annual value of -$12.1 million for FY2024, which is 11.86% down from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Other Working Capital Changes of -$18.1 million as of Q3 2025, which was down 363.37% from $6.9 million recorded in Q2 2025.
  • Iovance Biotherapeutics' 5-year Other Working Capital Changes high stood at $6.9 million for Q2 2025, and its period low was -$18.1 million during Q3 2025.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$2.7 million (2023), whereas its average is -$2.8 million.
  • The largest annual percentage gain for Iovance Biotherapeutics' Other Working Capital Changes in the last 5 years was 3,163.98% (2025), contrasted with its biggest fall of 560.52% (2025).
  • Quarterly analysis of 3 years shows Iovance Biotherapeutics' Other Working Capital Changes stood at -$2.7 million in 2023, then crashed by 34.23% to -$3.7 million in 2024, then plummeted by 560.52% to -$18.1 million in 2025.
  • Its last three reported values are -$18.1 million in Q3 2025, $6.9 million for Q2 2025, and $3.3 million during Q1 2025.